Shelter Pharma Limited (BOM:543963)

Shelter Pharma Statistics

Total Valuation

Shelter Pharma has a market cap or net worth of INR 497.07 million. The enterprise value is 473.31 million.

Market Cap	497.07M
Enterprise Value	473.31M

Important Dates

The last earnings date was Tuesday, September 2, 2025.

Earnings Date	Sep 2, 2025
Ex-Dividend Date	Sep 23, 2025

Share Statistics

Shelter Pharma has 11.56 million shares outstanding.

Current Share Class	11.56M
Shares Outstanding	11.56M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	56.29%
Owned by Institutions (%)	n/a
Float	4.79M

Valuation Ratios

The trailing PE ratio is 6.87.

PE Ratio	6.87
Forward PE	n/a
PS Ratio	0.98
PB Ratio	1.16
P/TBV Ratio	1.16
P/FCF Ratio	17.55
P/OCF Ratio	9.07
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.70, with an EV/FCF ratio of 16.71.

EV / Earnings	6.54
EV / Sales	0.93
EV / EBITDA	4.70
EV / EBIT	4.83
EV / FCF	16.71

Financial Position

The company has a current ratio of 7.19, with a Debt / Equity ratio of 0.02.

Current Ratio	7.19
Quick Ratio	2.79
Debt / Equity	0.02
Debt / EBITDA	0.10
Debt / FCF	0.37
Interest Coverage	7,540.77

Financial Efficiency

Return on equity (ROE) is 18.43% and return on invested capital (ROIC) is 15.29%.

Return on Equity (ROE)	18.43%
Return on Assets (ROA)	14.21%
Return on Invested Capital (ROIC)	15.29%
Return on Capital Employed (ROCE)	22.43%
Revenue Per Employee	7.34M
Profits Per Employee	1.05M
Employee Count	69
Asset Turnover	1.17
Inventory Turnover	3.24

Taxes

In the past 12 months, Shelter Pharma has paid 24.40 million in taxes.

Income Tax	24.40M
Effective Tax Rate	25.21%

Stock Price Statistics

The stock price has increased by +2.11% in the last 52 weeks. The beta is 0.62, so Shelter Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+2.11%
50-Day Moving Average	44.47
200-Day Moving Average	46.50
Relative Strength Index (RSI)	39.51
Average Volume (20 Days)	21,150

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shelter Pharma had revenue of INR 506.60 million and earned 72.37 million in profits. Earnings per share was 6.26.

Revenue	506.60M
Gross Profit	136.29M
Operating Income	98.03M
Pretax Income	96.77M
Net Income	72.37M
EBITDA	100.71M
EBIT	98.03M
Earnings Per Share (EPS)	6.26

Balance Sheet

The company has 34.20 million in cash and 10.44 million in debt, giving a net cash position of 23.76 million or 2.06 per share.

Cash & Cash Equivalents	34.20M
Total Debt	10.44M
Net Cash	23.76M
Net Cash Per Share	2.06
Equity (Book Value)	427.21M
Book Value Per Share	36.96
Working Capital	286.50M

Cash Flow

In the last 12 months, operating cash flow was 54.82 million and capital expenditures -26.51 million, giving a free cash flow of 28.32 million.

Operating Cash Flow	54.82M
Capital Expenditures	-26.51M
Free Cash Flow	28.32M
FCF Per Share	2.45

Margins

Gross margin is 26.90%, with operating and profit margins of 19.35% and 14.29%.

Gross Margin	26.90%
Operating Margin	19.35%
Pretax Margin	19.10%
Profit Margin	14.29%
EBITDA Margin	19.88%
EBIT Margin	19.35%
FCF Margin	5.59%

Dividends & Yields

This stock pays an annual dividend of 0.35, which amounts to a dividend yield of 0.79%.

Dividend Per Share	0.35
Dividend Yield	0.79%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	5.59%
Buyback Yield	n/a
Shareholder Yield	0.78%
Earnings Yield	14.56%
FCF Yield	5.70%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shelter Pharma has an Altman Z-Score of 9.37 and a Piotroski F-Score of 3.

Altman Z-Score	9.37
Piotroski F-Score	3